CareDx Unveils New Patient-Centered Medication Management Features on AlloCare Mobile Health App

Loading

Integration of MedActionPlan PRO Facilitates Patient-Clinician Interaction to Improve Medication Adherence

BRISBANE, Calif.–(BUSINESS WIRE)– CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that its AlloCare® mobile health app features expanded medication adherence and patient-provider communication capabilities resulting from the successful integration of MedActionPlan®, an acquisition made last year. Read the full press release on CareDx.com.

Loading